These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19861353)

  • 1. The angiotensin II type 2 receptor in the brain.
    Horiuchi M; Mogi M; Iwai M
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):1-6. PubMed ID: 19861353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin II receptor blockers on dementia.
    Mogi M; Horiuchi M
    Hypertens Res; 2009 Sep; 32(9):738-40. PubMed ID: 19727113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-different effect of angiotensin II type 2 receptor on ischemic brain injury and cognitive function.
    Sakata A; Mogi M; Iwanami J; Tsukuda K; Min LJ; Fujita T; Iwai M; Ito M; Horiuchi M
    Brain Res; 2009 Dec; 1300():14-23. PubMed ID: 19729000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
    Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
    Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CNS renin-angiotensin system.
    von Bohlen und Halbach O; Albrecht D
    Cell Tissue Res; 2006 Nov; 326(2):599-616. PubMed ID: 16555051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II type 1 receptor blockade: a novel therapeutic concept.
    Johnston CI
    Blood Press Suppl; 2000; 1():9-13. PubMed ID: 11059629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
    Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C
    Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuum.
    Chrysant SG
    Clin Ther; 2008; 30 Pt 2():2181-90. PubMed ID: 19281913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin 2 type 2 receptor activity and ischemic stroke severity.
    Ovbiagele B; Kidwell CS; Starkman S; Selco SL; Rajajee V; Razinia T; Saver JL
    Neurology; 2005 Sep; 65(6):851-4. PubMed ID: 16186522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats.
    Takemori K; Ishida H; Ito H
    Life Sci; 2005 Sep; 77(18):2233-45. PubMed ID: 15963533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angiotensin II-receptor antagonists compared to other antihypertensives: still insufficient evidence for reducing the risk of cerebrovascular incidents].
    Meerum Terwogt JM; Koopmans RP; Roos YB; van Montfrans GA
    Ned Tijdschr Geneeskd; 2008 Jan; 152(2):71-5. PubMed ID: 18265794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the central renin-angiotensin system in Parkinson's disease.
    Mertens B; Vanderheyden P; Michotte Y; Sarre S
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):49-56. PubMed ID: 19861346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system.
    Hamaguchi R; Takemori K; Inoue T; Masuno K; Ito H
    Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1151-5. PubMed ID: 18518883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecule-specific effects of angiotensin II-receptor blockers independent of the renin-angiotensin system.
    Kurtz TW; Pravenec M
    Am J Hypertens; 2008 Aug; 21(8):852-9. PubMed ID: 18535538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of dual Renin Angiotensin aldosterone system blockade for the treatment of cardiovascular diseases.
    Chrysant SG
    Am J Cardiol; 2010 Mar; 105(6):849-52. PubMed ID: 20211330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage.
    Gelosa P; Pignieri A; Fändriks L; de Gasparo M; Hallberg A; Banfi C; Castiglioni L; Turolo L; Guerrini U; Tremoli E; Sironi L
    J Hypertens; 2009 Dec; 27(12):2444-51. PubMed ID: 19680135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.